Earnings Call Summary | P3 Health Partners(PIII.US) Q1 2024 Earnings Conference
Earnings Call Summary | P3 Health Partners(PIII.US) Q1 2024 Earnings Conference
The following is a summary of the P3 Health Partners Inc. (PIII) Q1 2024 Earnings Call Transcript:
以下是 P3 Health Partners Inc. (PIII) Q1 2024 業績會議紀要:
Financial Performance:
金融業績：
P3 Health Partners reported Q1 2024 revenue of approximately a 29% increase year-over-year.
Medicare lives increased by 23% year-over-year reaching 126,800.
The company saw a substantial decrease (26%) in operating expenses down to $26.2 million.
The reported adjusted EBIDTA loss was $19.8 million, same as in Q1 2023.
Total revenue reached $388 million including the capitated revenue for the quarter of $384 million, reflecting a 29% growth compared to the prior year.
However, an adjusted EBITDA loss of $52 per member per month was observed.
P3 Health Partners 報告，Q1 2024 營業收入約爲同比增長29%。
醫療保險受益人同比增長23%，達到126,800。
公司營業費用大幅下降（26%），降至 2620 萬美元。
報道的調整後息稅折舊及攤銷前虧損額爲 1980 萬美元，與 Q1 2023 相同。
總收入達到 3.88 億美元，包括本季度協議收入 3.84 億美元，同比增長 29%。
然而，調整後每位受益人每月虧損 52 美元。
Business Progress:
業務進展：
The company reaffirmed its 2024 full-year guidance expecting to maintain Medicare Advantage members within the 125,000 and 135,000 range and predicting revenue to be within $1.45 billion and $1.55 billion.
They continue focusing on value-based care with a potential significant reserve release due to membership growth, increasing persistency, and funding.
P3 will be expanding into six new counties adding 8,000 to 10,000 more lives with an existing payer partner.
A strategic tie-up is announced with Innovaccer to implement an AI platform improving predictive modelling and quality.
Dr. Aric Coffman is now the new CEO replacing Sherif Abdou who will remain as an adviser.
The company anticipates its ACO REACH program, having had substantial growth, to contribute more significantly to future results with the goal of enhancing partnerships and outcomes in value-based care.
公司重申 2024 年全年指導，預計醫療保險會員人數在 125,000 至 135,000 範圍內，並預測營業收入在 14.5 億美元至 15.5 億美元之間。
他們繼續專注於價值爲本的醫療護理，由於會員增長、提高保留率和融資等因素，可能會出現相當大的準備金釋放。
P3 將擴展到六個新縣，向現有付款方合作伙伴添加 8,000 至 10,000 名更多的生命。
宣佈與 Innovaccer 簽署戰略合作，實施人工智能平台，提高預測建模和質量。
Aric Coffman 博士現爲新 CEO，取代將繼續擔任顧問的 Sherif Abdou。
該公司預計其 ACO REACH 項目將會有顯著增長，爲未來的業績做出更重要的貢獻，旨在增強價值爲本的醫療護理合作伙伴關係和結果。
More details: P3 Health Partners IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。